NLRP3 and intervertebral disk degenerative disorder: As reported previously, the inhibition of pyroptosis could be a therapeutic strategy for IDD [47,48] , and rosuvastatin could regulate the NLRP3 inflammasome in the cardiovascular system [35,36] , digestive system[49] and nervous system[50].